RGNT — Regentis Biomaterials Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual balance sheet for Regentis Biomaterials, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS/A
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.38	2.74	1.24	0.345	0.229
Net Total Accounts Receivable
Net Total Receivables	0.007	0.045	0.026	0.008	0.073
Prepaid Expenses
Total Current Assets	1.39	3.12	1.72	0.36	0.482
Total Assets	1.39	3.12	1.72	0.36	0.482
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.54	2.72	2.61	3.14	6.06
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.71	9.58	9.77	11.2	6.06
Non Redeemable Preferred Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-1.33	-6.47	-8.05	-10.8	-5.58
Total Liabilities & Shareholders' Equity	1.39	3.12	1.72	0.36	0.482
Total Common Shares Outstanding